CPHI Milan 2
CPHI Milan newsletter
PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical
News

Noramco and SPI Pharma sign agreement to develop ready-to-implement, patient-friendly formulations for pharmaceutical manufacturers

Noramco, a global leader in the manufacture and supply of controlled substance active pharmaceutical ingredients (APIs), and SPI Pharma, a global leader in the manuf...
Continue Reading →
Uncategorised

Mitch Lewandowski Joins PCI Pharma Services as Executive Director of Quality

Lewandowski to lead Quality activities for Rockford, Illinois commercial packaging Center of Excellence Global pharmaceutical outsourcing services provider PCI P...
Continue Reading →
News

Will Facebook’s data-scraping woes bleed into healthcare and pharma?

 Another internet data scandal—this time Facebook and Cambridge Analytica—has consumers buzzing about the safety of their personal information. Will pe...
Continue Reading →
Rychiger AG
N-S

Rychiger AG

Rychiger AG, based in Switzerland, is one of the world’s leading suppliers of customer-specific solutions for packaging machines in the coffee & tea, retort...
Continue Reading →
News

Eisai, Nichi-Iko Pharma enters strategic partnership

Both companies will promote cooperation in building Eisai's Total Inclusive Ecosystem as well as collaboration on the active pharmaceutical ingredient (API) busi...
Continue Reading →
News

PCI’s Tredegar Site Announces Significant Expansion of Analytical Laboratories at its Center of Excellence for Contained Manufacturing

Global pharmaceutical outsourcing services provider PCI Pharma Services (PCI) is pleased to announce a laboratory expansion at its site in Tredegar, Wales, U...
Continue Reading →
News

Napp secures distribution rights to Celltrion’s Herzuma

Napp Pharmaceuticals has secured itself exclusive UK distribution rights to Celltrion Healthcare’s Herceptin biosimilar Herzuma. Herzuma (trastuzumab) was approv...
Continue Reading →
Uncategorised

Real world data back Sanofi’s Toujeo for type I diabetes

Sanofi has unveiled real-world data from the UK showing the efficacy of its long-acting basal insulin analogue Toujeo in treating patients with type I diabetes....
Continue Reading →
News

Lundbeck snaps up Parkinson’s candidate via Prexton buy

Lundbeck has announced plans to buy Prexton Therapeutics in a deal valued at up to 905 million euros. The move gives the Danish drugmaker access to Prexton’s fo...
Continue Reading →
News

Loncar introduces China BioPharma Index

LCHINA is the first and only stock market index available to the public that follows China’s biopharma industry from both its regional and U.S. listed perspective. ...
Continue Reading →

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026